Medicus Pharma MDCX
NASDAQ MDCX
$0.16 +0.00 (+2.94%)
As of: Sep 30, 2026 · 10:25 AM EDT

Medicus Pharma (MDCX) Short term Debt (2025 - 2026)

Updated

Medicus Pharma (MDCX) recorded Short term Debt of $3.5 million in Q2 2026, down 25.5% from $4.7 million a year earlier.

Analysis

Medicus Pharma (MDCX) Short term Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Medicus Pharma reported Short term Debt of $5.25 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Medicus Pharma 9.03 Mn -33.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.50 Mn
Dec 31, 2025 5.25 Mn
Sep 30, 2025 6.79 Mn
Jun 30, 2025 4.70 Mn
API Access

Medicus Pharma Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=MDCX&period=max&api_key=YOUR_API_KEY